Want to see GB:EMVC full AI Analyst Report?
EMVC Stock Chart & Stats
53.50 p
0.00 p(0.00%)
At close: 4:00 PM EDT
53.50 p
0.00 p(0.00%)
Day’s Range― - ―
52-Week Range40.00 p - 62.00 p
Previous CloseN/A
Volume9.91K
Average Volume (3M)31.99K
Market Cap
£14.96M
Enterprise Value16.47 p
Total Cash (Recent Filing)£511.00K
Total Debt (Recent Filing)£2.60M
Price to Earnings (P/E)―
Beta0.58
Next Earnings
Sep 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding27,967,531
10 Day Avg. Volume35,929
30 Day Avg. Volume31,987
Financial Highlights & Ratios
PEG Ratio5.74
Price to Book (P/B)1.04
Price to Sales (P/S)5.52
P/FCF Ratio-12.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.03
Revenue Forecast (FY)£3.43M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained revenue expansion, even from a small base, can broaden the portfolio platform’s commercialization potential and improve operating leverage if investment activity and portfolio support scale efficiently.
Strong Gross MarginsHigh gross margins indicate attractive underlying economics in the reported activities, providing a foundation for future profitability if NetScientific controls platform costs and converts growth into sufficient operating scale.
Low Historical LeverageHistorically low leverage gives NetScientific more financial flexibility than a highly indebted investment platform, helping it support portfolio companies and fund operations while limiting near-term balance-sheet pressure.
Bears Say
Persistent Cash BurnContinued operating and free-cash-flow deficits show that the business is not self-funding. Reliance on external capital or existing resources can constrain follow-on investment and increase execution risk over the medium term.
Structural Operating LossesDeep operating losses indicate that platform and portfolio-support costs remain too high relative to revenue. A near-breakeven net result is encouraging but does not yet demonstrate durable earnings quality or operating leverage.
Rising Debt And Declining EquityHigher debt alongside a shrinking equity base reduces financial resilience if losses and cash burn persist. It may also limit NetScientific’s ability to provide capital to portfolio companies without further fundraising or asset monetization.
NetScientific News
EMVC FAQ
What was NetScientific PLC’s price range in the past 12 months?
NetScientific PLC lowest share price was 40.00 p and its highest was 62.00 p in the past 12 months.
What is NetScientific PLC’s market cap?
NetScientific PLC’s market cap is £14.96M.
When is NetScientific PLC’s upcoming earnings report date?
NetScientific PLC’s upcoming earnings report date is Sep 24, 2026 which is in 30 days.
How were NetScientific PLC’s earnings last quarter?
Currently, no data Available
Is NetScientific PLC overvalued?
According to Wall Street analysts NetScientific PLC’s price is currently Overvalued.
Does NetScientific PLC pay dividends?
NetScientific PLC does not currently pay dividends.
What is NetScientific PLC’s EPS estimate?
NetScientific PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NetScientific PLC have?
NetScientific PLC has 27,967,531 shares outstanding.
What happened to NetScientific PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NetScientific PLC?
Currently, no hedge funds are holding shares in GB:EMVC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NetScientific PLC
EMV Capital plc operates as a venture capital firm, primarily targeting investments across the full spectrum of early-stage funding, from seed rounds through to mid-stage and growth capital. Its investment mandate spans diverse high-growth sectors, including sustainability, life science, technology, transformative biomedical, deep tech, semiconductors, industrials, robotics, and artificial intelligence. The firm also places a strong emphasis on healthcare technologies, particularly digital health, diagnostics, and therapeutics, with a specific focus on ventures that enhance the lives and health outcomes of individuals battling chronic illnesses. Within digital health, core interests lie in data analytics, advanced wearable devices, and other related technologies. Geographically, EMV Capital seeks opportunities within developed European markets, including its home base in the United Kingdom, as well as the United States. While typical investment sizes reach up to £15 million (approximately $20.32 million), the firm retains the flexibility to commit larger sums. A strategic preference is to secure a controlling stake in key subsidiary companies, with investments primarily executed via its balance sheet. Established in 2008, EMV Capital plc operates from its headquarters in London, UK, with an additional presence in Beaconsfield.